We are live on
!
Find out more
SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
78 hedge funds and large institutions have $75M invested in Sorrento Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 17
16% more call options, than puts
Call options by funds: $313K | Put options by funds: $270K
20% less funds holding
Funds holding: 97 → 78 (-19)
49% less capital invested
Capital invested by funds: $147M → $75M (-$72.3M)
66% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 29
Holders
78
Holders Change
-19
Holders Change %
-19.59%
% of All Funds
1.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
34
Reduced
17
Closed
29
Calls
$313K
Puts
$270K
Net Calls
+$43K
Net Calls Change
+$1.79M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$6.19M |
| 2 |
Renaissance Technologies
New York
|
+$2.32M |
| 3 |
Citigroup
New York
|
+$1.81M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.74M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$808K |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$6.02M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.91M |
| 3 |
State Street
Boston,
Massachusetts
|
-$2.96M |
| 4 |
IP
Intellectus Partners
San Francisco,
California
|
-$2.45M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.6M |